Guidance Document: Certificates of Supplementary Protection - summary

From Health Canada


This guidance document provides an overview of the certificate of supplementary protection (CSP) application process for applicants. This includes information on

  • how to provide a CSP application
  • the service standard for processing applications
  • the roles and responsibilities of applicants and Health Canada

Please note our new CSP Application form in which the United Kingdom has been added to the list of countries in the "Attestation as to Timely Submission" section.

Who this guide is for

  • Owners of Canadian patents
  • Canadian and foreign drug companies
  • Canadian and foreign regulatory bodies

In this guide

View complete guide
Download PDF (395.25 KB, 23 pages)

Details and history

Published: September 21, 2017

Updated: January 6, 2021; May 15, 2019; September 4, 2018

Part of topic(s): Guidance on Certificates of Supplementary Protection

For assistance

Questions or concerns related to this Guidance Document should be directed to the Office of Patented Medicines and Liaison.

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: